LifeWatch publishes results of Annual General Meeting

Zug/Switzerland, April 26, 2017 - LifeWatch AG (SIX Swiss Exchange: LIFE), a leading developer and provider of medical solutions and remote diagnostic monitoring services in the digital health market, publishes the results of today's Annual General Meeting. Fifty-one shareholders attended the meeting in Zurich and approximately 11,262,000 votes or 60.95% of the share capital were represented. The outcome of the motions are summarized below:

• Approval of the Annual Report 2016 and the allocation of the balance sheet result 2016.
• Discharge for fiscal year 2016 was granted to Dr. Robert Bider, Antoine Kohler, Raymond W. Cohen, Jinsheng Dong, Antoine Hubert, Thomas Rühle, Patrick Schildknecht, Dr. Stephan Rietiker, Dr. Christoph Heinzen, Stephanie Kravetz, Andrew Moore, Michael Turchi and Stefan Vogt.
• Elections to the Board of Directors until the next Ordinary Annual General Meeting 2018
• Dr. Robert Bider, Raymond W. Cohen, Thomas Rühle and Patrick Schildknecht were re-elected.
• As recommended by Erhard Lee, representative of AMG Analysen & Anlagen, Markus Breitenmoser was newly elected as a member of the Board.
• Xu Shenlu, recommended by Jinsheng Dong, representative of Himalaya TMT Funds, was not elected as a new member of the Board.
• Dr. Robert Bider was re-elected as Chairman of the Board of Directors.
• Elected as members of the Compensation Committee: Thomas Rühle and Raymond W. Cohen.
• The Annual General Meeting did not approve the proposed amendments to the Articles of Incorporation on the introduction of Article 3bis (conditional capital).
• The Annual General Meeting approved the total compensation to be paid to the Board of Directors for the financial year 2018 in the maximum amount of CHF 700,000.
• The Annual General Meeting did not approve the proposed fixed compensation for the Executive Management Team for the financial year 2018 in the maximum amount of CHF 2,100,000. In a second vote, the Annual General Meeting did approve the proposed fixed compensation for the Executive Management Team for the financial year 2018 in the maximum amount of CHF 1,900,000.
• The Annual General Meeting approved the proposed variable compensation for the Executive Management Team for the financial year 2016 of the maximum amount of CHF 0.
• Re-election of the independent proxy: Yves Endrass, Zurich
• Re-election of the statutory auditors: PricewaterhouseCoopers, Zurich

For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com

About LifeWatch AG

LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes. LifeWatch AG has operative subsidiaries in the United States, in Switzerland, Israel and Turkey, and is the parent company of LifeWatch Services Inc., LifeWatch Technologies, Ltd. and LifeWatch Turkey Holding AG (joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading manufacturer of digital health products. LifeWatch Sağlık Hizmetlerine A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and provider of mobile cardiac telemetry services in Turkey. For additional information, please visit www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
https://www.lifewatch.com/Investor-Relations/Alert-Service.html

This press release includes forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding future results of operations and financial position, the business strategy, and plans and objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect" and similar expressions are intended to identify forward-looking statements. LifeWatch AG has based these forward-looking statements largely on current expectations and projections about future events and financial trends that it believes may affect the financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances described may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. All forward-looking statements are based only on data available to LifeWatch AG at the time of the issue of this press release. LifeWatch AG does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND MUST NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.